Evidence map›Paper›PMID 42368976›Full record

ReviewPathology oncology research : POR2026

Multiple subcutaneous nodules as the primary presentation of angioimmunoblastic T-cell lymphoma: a case report and literature review.

Ying Li, Yanxia Cai, Xiaoyan Xu

Abstract readCase ReportsReview
In one paragraph

Review in Pathology oncology research : POR, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ying LiDepartment of Pathology, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, China.
Yanxia CaiDepartment of Dermatology, Sanya Central Hospital (The Third People's Hospital of Hainan Province), Sanya, China.
Xiaoyan XuDepartment of Pathology, College of Basic Medicine of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angioimmunoblastic T-cell lymphoma (AITL) frequently involves the skin, typically presenting as rash or pruritus. However, AITL presenting primarily with multiple subcutaneous nodules is exceedingly rare and poses significant diagnostic challenges, often leading to misdiagnosis. We reported a 53-year-old man who presented with widespread subcutaneous nodules. He had a 1-month history of multiple painless subcutaneous nodules on the trunk and upper limbs. Physical examination revealed multiple firm nodules measuring 0.5-2 cm, accompanied by dark red plaques. Laboratory investigations showed mild anemia, elevated inflammatory markers, decreased IgA levels, and increased IgE levels. Imaging findings demonstrated generalized lymphadenopathy. Histopathological examination revealed effacement of the lymph node architecture with atypical lymphoid cells; immunohistochemistry was positive for CD3, CD4, PD-1, and EBER. A diagnosis of AITL of stage III was established. The patient achieved complete remission (CR) after 6 cycles of chidamide plus CHOP chemotherapy, with no evidence of recurrence at 6 months. This case broadens the recognized cutaneous spectrum of AITL and underscores the importance of considering lymphoma in the differential diagnosis of unexplained subcutaneous nodules.

Indexed as

Immunoblastic LymphadenopathyLymphoma, T-CellSkin NeoplasmsSubcutaneous TissueAntineoplastic Combined Chemotherapy ProtocolsCyclophosphamideHumansMaleMiddle AgedPrednisoneVincristineCyclophosphamidePrednisoneVincristineangioimmunoblastic T-cell lymphomacase reportcutaneous manifestationlymphadenopathysubcutaneous nodules

Identifiers

PMID42368976
PMCPMC13293995

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.